Victoza Sales Data
| Rank 44 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Victoza U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 44 ( 5) |
$301,414 | 9.59% | 639 | 3.73% |
| Q3 2013 | 49 (2) |
$275,033 | 4.95% | 616 | -0.65% |
| Q2 2013 | 51 (9) |
$262,064 | 8.23% | 620 | 2.14% |
| Q1 2013 | 60 (8) |
$242,143 | 6.43% | 607 | 9.76% |
| Q4 2012 | 68 (6) |
$227,520 | 8.78% | 553 | 7.17% |
| Q3 2012 | 74 (24) |
$209,163 | 27.22% | 516 | 18.08% |
| Q2 2012 | 98 ( ) |
$164,409 | n/a | 437 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
